Clinical trial
Interferon Alfa With or Without Isotretinoin in Treating Patients With…
NCT00002737 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002737 |
|---|---|
| Title | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer |
| Official title | A RANDOMIZED PHASE II TRIAL OF INTERFERON ALPHA-2A WITH AND WITHOUT 13-CIS RETINOIC ACID IN PATIENTS WITH PROGRESSIVE MEASURABLE METASTATIC RENAL CELL CARCINOMA. Amendment Protocol: Extension to a Randomized Phase III Trial |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, chemotherapy, isotretinoin |
| Enrollment | 320 |
| Start date | Mar 1, 1996 |
| Primary completion | Jan 1, 2001 |
| First posted | May 11, 2004 |
| Last update posted | Jul 11, 2012 |
| Countries | Belgium, Hungary, Italy, Netherlands, Norway, Russia, Switzerland, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: